IL-8 producing cells in patients with Behcet's disease

Clinical and Experimental Rheumatology

Volumn 18, Issue 2, 2000, Pages 249-251

  Mantas, C ^a   Direskeneli, H ^a,b   Oz D ^a   Yavuz, S ^a   Akoglu, T ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Behcet's disease; IL 8; mRNA

Indexed keywords

INTERLEUKIN 8;

ADULT; ARTICLE; BEHCET DISEASE; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ACTINS; ADULT; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; CELL SEPARATION; CELLS, CULTURED; DNA PRIMERS; FEMALE; GRANULOCYTES; HUMANS; INTERLEUKIN-8; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPSIS;

EID: 0034076216     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ERGUN T, GURBUZ O, HARVELL J, JORIZZO J, WHITE W: The histopathology of pathergy: A chronological study of skin hyperreactivity in Behçet's disease. Int J Dermatology 1998; 37: 929-33.
2. FUJI N, MINAGAWA T, NAKANE A et al.: Spontaneous production of γ-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease. J Immunol 1983; 130: 1683-6.
3. AKOGLU T, DIRESKENELI H, YAZICI H, LAWRENCE R: TNF, soluble IL-2 R and soluble CDS in Behçet's disease. J Rheumatol 1990; 17: 1107-8.
4. HAMZAOUI K, HAMZA M, AYED K: Production of TNF-α and IL-1 in active Behçet's disease. J Rheumatol 1990; 17: 1428-9.
5. TURAN B, GALLATI H, ERDI H, GURLER A, MICHEL BA, VILLIGER PM: Systemic levels of T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 1997; 24: 128-32.
6. MEGE JL, DILSEN N, SANGUEDOLCE V et al.: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin IL-6, IL-8 and increased neutrofil superoxide generation in Behçet's disease. A comparative study with familial mediterranean fever and healthy subjects. J Rheumatol 1993; 20: 1544-9.
7. ITOH R, TAKENAKA T, OKITSU NEGISHI S et al.: Interleukin 8 in Behçet's disease. J Dermatol 1994; 21: 397-404.
8. AL-DALAAN A, AL-SEDAIRI S, AL BALAA S et al.: Enhanced IL-8 secretion in circulation of patients with Behçet's disease. J Rheumatol 1995; 22: 904-7.
9. SAHIN S, AKOGLU T, DIRESKENELI H, SEN LS, LAWRENCE R: Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996; 55: 128-33.
10. ÖZORAN K, AYDINTUG O, TOKGÖZ G et al.: Serum levels of IL-8 in patients with Behçet's disease. Ann Rheum Dis 1995; 54: 610.
11. HEBERT C, BAKER J: Interleukin-8: A review. Cancer Investigation 1993; 11: 743-50.
12. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
13. CARRE P, MORTENSON R, KING TE et al.: Increased expression of the IL-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 1991; 88: 1802-10.
14. INOGUE K, SUGYYAMA H, OGAWA H et al.: WT1 as a prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994; 84: 3071-9.
15. DIRESKENELI H, EKSIOGLU-DEMIRALP E, KIBAROGLU A, YAVUZ S, ERGUN T, AKOGLU T: Oligoclonal T cell expansions in patients with Behçet 's disease. Clin Exp Immunol 1999; 117: 166-70.
16. KANEKO S, SUZUKI N, YAMASHITA N et al.: Characterization of T cells specific for an epitope of human 60 kD heat shock protein (hsp) in patients with Behçet's disease in Japan. Clin Exp Immunol 1997; 108: 204-11.
17. TAKENO M, KARIONE A, YAMASHITA N et al.: Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995; 426-33.
18. BUDAK-ALPDOGAN T, DEMIRÇAY Z, ALPDOGAN Ö et al.: Skin hyper-reactivity of Behçet's patients (pathergy reaction) is also positive in interferon-alpha treated chronic myeloid leukemia patients, indicating similarly altered neutrophil functions in both disorders. Br J Rheumatol 1998; 37: 1148-51.